EFFICACY OF CHECKPOINT INHIBITOR IMMUNOTHERAPY DRUG PEMBROLIZUMAB (KEYTRUDA) FOR TREATMENT OF ADVANCED CERVICAL CANCER Meeting Abstract

International Collaboration

cited authors

  • Ahmed, F.; Shah, Z.; Khan, I.; Bhatnagar, A.; Garimella, R.; Mishra, S.; Gudapati, S.; Bobba, S. H.; Zaidi, S.; Andrews, K.; Salman, U.; Yukselen, Z.; Guntipalli, P.; Zarrar, R.; Nya, G. Enebong; Ahmad, S.

authors

Publication Date

  • March 1, 2021

webpage

published in

category

start page

  • A32

end page

  • A32

volume

  • 31